Key Takeaways
- ACOG, the AAP, and the Academy of Breastfeeding Medicine support breastfeeding for women stabilized on buprenorphine or methadone
- The amount of MAT medication transferred through breast milk is clinically insignificant and unlikely to affect the infant
- Breastfeeding may reduce the severity and duration of neonatal abstinence syndrome in opioid-exposed newborns
- Breastfeeding should be discontinued if a mother returns to illicit drug use or is not adhering to her MAT regimen
- Skin-to-skin contact and breastfeeding promote bonding and attachment, which are protective factors for maternal recovery
- Trust SoCal coordinates with lactation consultants to provide integrated breastfeeding support within our maternal recovery program
Current Clinical Guidelines on Breastfeeding and MAT
The medical consensus on breastfeeding during medication-assisted treatment has shifted substantially over the past two decades. Where early guidance often discouraged breastfeeding for women on methadone or buprenorphine, current guidelines from ACOG, the American Academy of Pediatrics, and the Academy of Breastfeeding Medicine actively encourage breastfeeding for women who are stable in recovery, adhering to their MAT regimen, and not using illicit substances. This evidence-based position reflects decades of pharmacokinetic research demonstrating negligible infant medication exposure through breast milk.
At Trust SoCal in Fountain Valley, California, we integrate lactation support into our maternal recovery programming because the evidence demonstrates that breastfeeding confers significant benefits for both mother and infant in the context of medication-assisted treatment. Our clinicians help mothers navigate the complex information landscape around MAT and breastfeeding, empowering informed decisions free from stigma or misinformation.
ACOG Committee Opinion 711 states: "Breastfeeding should be encouraged in women who are stable on their opioid agonist, who are not using illicit drugs, and who have no other contraindications to breastfeeding." This guidance applies to both methadone and buprenorphine maintenance. Contact Trust SoCal at (949) 280-8360 for support navigating these decisions.
ACOG Guidelines and Recommendations
ACOG Committee Opinion 711, reaffirmed in 2020, provides the most authoritative obstetric guidance on breastfeeding in the context of opioid use disorder treatment. The opinion explicitly encourages breastfeeding for women on either methadone or buprenorphine maintenance who meet stability criteria. ACOG notes that the small amount of medication transferred through breast milk may actually provide a mild analgesic effect that eases neonatal withdrawal symptoms.
American Academy of Pediatrics Position
The AAP has revised its stance on breastfeeding and maternal opioid agonist therapy multiple times as evidence has accumulated. Current AAP guidance, consistent with ACOG, supports breastfeeding for mothers on stable doses of methadone or buprenorphine. The AAP emphasizes the well-documented benefits of breastfeeding for infant immune function, nutrition, and neurodevelopment as factors that outweigh the minimal medication exposure through breast milk.
- AAP guidelines note that breast milk provides immunological benefits particularly valuable for NAS-affected infants
- Pediatric monitoring for sedation, poor feeding, and respiratory depression is recommended as standard precaution
- The AAP supports rooming-in and skin-to-skin contact as nonpharmacological NAS interventions complementary to breastfeeding
Academy of Breastfeeding Medicine Protocol
ABM Clinical Protocol 21 provides the most detailed clinical guidance specifically addressing breastfeeding in the context of substance use disorders. This protocol offers decision trees for determining breastfeeding appropriateness, monitoring parameters for nursing infants, and guidance on managing common challenges that arise when mothers in MAT choose to breastfeed. Trust SoCal clinicians follow this protocol in developing individualized breastfeeding plans for our maternal clients.
- ABM Protocol 21 includes specific criteria for initiating, continuing, and discontinuing breastfeeding in MAT patients
- The protocol recommends urine drug screening as a component of ongoing breastfeeding eligibility assessment
- ABM provides guidance on managing breastfeeding during dose adjustments and medication transitions
Pharmacokinetics of MAT Medications in Breast Milk
Understanding how MAT medications transfer into and are metabolized in breast milk is essential for informed decision-making. Pharmacokinetic studies have consistently demonstrated that both methadone and buprenorphine pass into breast milk at very low concentrations relative to maternal plasma levels. The relative infant dose, a standard measure of medication exposure through breastfeeding, falls well below the 10 percent threshold generally considered the safety benchmark for nursing compatibility.
The oral bioavailability of these medications in the infant gut further reduces effective exposure. Even the small quantities present in breast milk undergo significant first-pass metabolism in the infant liver, resulting in serum concentrations that are typically undetectable or far below therapeutic thresholds. This pharmacokinetic profile provides the scientific foundation for clinical guidelines supporting breastfeeding during MAT.
Buprenorphine Transfer and Infant Exposure
Buprenorphine is highly protein-bound in maternal plasma, which limits its transfer into breast milk. Studies using liquid chromatography mass spectrometry have measured breast milk buprenorphine concentrations averaging 1.0 to 3.6 micrograms per liter, producing estimated relative infant doses of 0.1 to 0.4 percent of the maternal weight-adjusted dose. These levels are considered negligible by all major pharmacology references and clinical guidelines.
- Relative infant dose for buprenorphine through breast milk is approximately 0.1 to 0.4 percent, far below the 10 percent safety threshold
- Buprenorphine has low oral bioavailability in infants, meaning even ingested amounts are poorly absorbed from the gut
- No adverse effects attributable to buprenorphine exposure through breast milk have been documented in clinical studies
Methadone Transfer and Infant Exposure
Methadone passes into breast milk in quantities that vary with maternal dose but consistently remain below clinically significant levels. Research published in the Journal of Human Lactation found that breast milk methadone concentrations range from 27 to 260 micrograms per liter across typical maintenance doses. The relative infant dose averages 2 to 3 percent of the maternal weight-adjusted dose, well within the accepted safety range for breastfeeding compatibility.
- Methadone relative infant dose averages 2 to 3 percent regardless of maternal dose within typical maintenance ranges
- Daily infant methadone exposure through breast milk is estimated at 0.01 to 0.06 milligrams, a subclinical amount
- Breastfed infants of methadone-maintained mothers show no difference in developmental outcomes compared to formula-fed peers in longitudinal studies
The Role of Breast Milk in NAS Mitigation
Emerging evidence suggests that breastfeeding itself may help attenuate neonatal abstinence syndrome severity. A meta-analysis published in the Journal of Perinatology found that breastfed NAS-affected infants required pharmacological treatment less frequently, had shorter hospital stays, and experienced milder withdrawal symptom scores than formula-fed counterparts. The mechanism likely involves both the small amount of opioid agonist in breast milk providing a gradual taper and the calming physiological effects of breastfeeding itself.
- Breastfed infants with NAS have 50 percent shorter mean hospital stays compared to formula-fed infants with NAS
- Pharmacological treatment for NAS is required in approximately 50 percent fewer breastfed infants
- Skin-to-skin contact during breastfeeding activates oxytocin pathways that reduce infant stress responses
Eligibility Criteria and Contraindications
Not all mothers in medication-assisted treatment are appropriate candidates for breastfeeding. Clinical guidelines establish clear eligibility criteria that balance the benefits of breastfeeding against potential risks. The primary contraindications involve active illicit substance use, HIV-positive status, and certain medication combinations that could produce harmful effects in the nursing infant. Trust SoCal conducts individualized breastfeeding eligibility assessments as part of our maternal discharge planning process.
Eligibility assessment is not a one-time determination but an ongoing process that continues throughout the breastfeeding period. Changes in maternal substance use status, medication regimen, or clinical stability may necessitate reevaluation of breastfeeding appropriateness. Open communication between the mother, her MAT provider, and the infant's pediatrician is essential for maintaining safe breastfeeding practices throughout recovery.
Breastfeeding must be discontinued immediately if a mother returns to illicit substance use. Drugs such as methamphetamine, cocaine, and non-prescribed opioids pass readily into breast milk at concentrations that can cause serious harm to nursing infants. If you have relapsed while breastfeeding, contact Trust SoCal at (949) 280-8360 for crisis support and guidance on safe infant feeding alternatives.
Criteria Supporting Breastfeeding in MAT
Current guidelines identify several criteria that support breastfeeding eligibility for mothers in medication-assisted treatment. Meeting these criteria does not guarantee that breastfeeding is the right choice for every mother, but it establishes the medical foundation for considering breastfeeding as a safe and beneficial option.
- Stable adherence to prescribed MAT medication for a minimum of 30 days prior to delivery
- Negative urine drug screens for all illicit substances at delivery and during the postpartum period
- No concurrent use of benzodiazepines or other sedating medications that could compound infant sedation risk
Absolute Contraindications to Breastfeeding
Certain conditions represent absolute contraindications to breastfeeding regardless of MAT status. These include maternal HIV infection in resource-rich settings where safe formula alternatives are available, active illicit drug use, and specific medical conditions that independently preclude breastfeeding. Recognition of these contraindications is essential for protecting infant safety.
- Active use of methamphetamine, cocaine, PCP, or non-prescribed opioids is an absolute contraindication
- Maternal HIV-positive status in the United States contraindicates breastfeeding per CDC and AAP guidelines
- Active untreated tuberculosis requires separation and pumping rather than direct breastfeeding until treatment stabilization
Relative Contraindications Requiring Clinical Judgment
Some situations require individualized clinical judgment rather than absolute recommendations. High-dose methadone maintenance, concurrent psychotropic medications with sedating properties, and unstable recovery status represent relative contraindications that warrant careful risk-benefit analysis. Trust SoCal clinicians collaborate with pediatricians and MAT providers to make individualized recommendations in these complex scenarios.
- Concurrent use of sedating antihistamines or muscle relaxants requires evaluation of cumulative infant sedation risk
- Maternal hepatitis C without treatment does not contraindicate breastfeeding per AAP guidelines, though cracked or bleeding nipples warrant temporary suspension
- Intermittent cannabis use represents a relative contraindication with evolving evidence and varying expert opinion
Practical Guidance for Breastfeeding While on MAT
Successfully breastfeeding while on medication-assisted treatment requires practical preparation, ongoing support, and proactive management of common challenges. Many mothers in MAT face unique obstacles including delayed lactogenesis, infant difficulties related to NAS, hospital policies that may not accommodate rooming-in, and misinformation from well-meaning but poorly informed providers. Anticipating and addressing these challenges proactively improves breastfeeding success rates.
Trust SoCal prepares maternal clients for breastfeeding during the prenatal period with education, skill building, and coordination with delivery hospitals. Our staff communicates directly with hospital lactation consultants and neonatal teams to ensure that clients' breastfeeding plans are understood and supported during the inpatient postpartum stay, reducing the fragmented care that often undermines breastfeeding initiation for mothers in recovery.
Initiating Breastfeeding in the Hospital
The first hours after delivery represent the optimal window for breastfeeding initiation. Immediate skin-to-skin contact and early latching within the first hour support both lactation establishment and mother-infant bonding. For mothers in MAT, communicating the breastfeeding plan to the delivery team in advance helps ensure consistent support and avoids contradictory advice from rotating staff members.
- Request skin-to-skin contact immediately after delivery regardless of delivery method, as this promotes early breastfeeding
- Bring documentation of MAT provider clearance for breastfeeding to the hospital to facilitate consistent care
- Request lactation consultant support within the first 24 hours to address any latch or positioning challenges
Managing Common Breastfeeding Challenges
Mothers in MAT may experience challenges common to all breastfeeding mothers plus additional issues related to their medication status and recovery circumstances. NAS-affected infants may have difficulty with latch, suck-swallow coordination, and sustained feeding due to irritability, tremors, or sleepiness. Patient persistence, lactation consultant support, and supplementary feeding strategies when needed can help overcome these early obstacles.
- NAS-affected infants may require more frequent, shorter feeding sessions to accommodate their tolerance and state regulation
- Paced bottle feeding with expressed breast milk can supplement direct breastfeeding when the infant struggles to latch
- Breast pumping between feeds helps establish milk supply even when direct feeding is temporarily difficult
Weaning Considerations for MAT Mothers
Weaning decisions should be based on the mother's and infant's individual circumstances rather than arbitrary timelines. When weaning is chosen, gradual reduction in breastfeeding frequency over several weeks is recommended to prevent engorgement, mastitis, and abrupt hormonal shifts that could destabilize maternal mood and recovery. For infants who have been receiving small amounts of MAT medication through breast milk, abrupt weaning could theoretically precipitate mild withdrawal symptoms.
- Gradual weaning over 2 to 4 weeks reduces the risk of maternal engorgement and hormonal mood disruption
- Monitoring the infant for irritability or feeding changes during weaning helps identify any withdrawal response
- Weaning does not require any changes to the mother's MAT medication dosing
Other Medications and Substances During Breastfeeding
Beyond MAT medications, mothers in recovery often take additional medications for co-occurring conditions such as depression, anxiety, chronic pain, and sleep disorders. Each medication must be individually evaluated for breastfeeding compatibility. The LactMed database, maintained by the National Library of Medicine, provides the most current and comprehensive reference for medication safety during lactation and should be consulted for any new prescription.
Substance use of any kind during breastfeeding introduces risks that vary dramatically by substance type, dose, and pattern of use. While MAT medications are safe during breastfeeding, illicit substances and many recreational drugs are not. Alcohol, cannabis, and nicotine each present distinct profiles of risk that breastfeeding mothers need to understand to make informed choices that protect their infants.
The LactMed database at toxnet.nlm.nih.gov is a free, evidence-based resource that provides detailed information on drug transfer into breast milk, potential infant effects, and alternative medications. Trust SoCal clinical staff reference LactMed when developing comprehensive medication plans for breastfeeding clients.
Psychiatric Medications and Breastfeeding Compatibility
Many psychiatric medications commonly prescribed during postpartum recovery are compatible with breastfeeding. SSRIs, particularly sertraline and paroxetine, have the most reassuring safety profiles. Mood stabilizers, antipsychotics, and anxiolytics have more variable safety data, requiring individualized assessment. The clinical principle guiding these decisions balances the risk of untreated maternal psychiatric illness against the minimal medication exposure through breast milk.
- Sertraline produces negligible infant serum levels and is the preferred SSRI for breastfeeding mothers
- Lamotrigine passes into breast milk at relatively high concentrations and requires infant monitoring if used
- Benzodiazepines should be avoided during breastfeeding due to infant sedation risk and maternal abuse potential
Alcohol, Cannabis, and Nicotine Considerations
Alcohol transfers freely into breast milk at concentrations approximately equal to maternal blood alcohol levels. Even moderate alcohol consumption during breastfeeding can impair infant motor development and sleep patterns. Cannabis metabolites accumulate in breast milk due to high fat solubility and can be detected in infant urine for weeks. Nicotine passes into breast milk but breastfeeding benefits are generally considered to outweigh nicotine exposure when the mother cannot quit.
- There is no known safe level of alcohol consumption during breastfeeding, and "pump and dump" strategies are unreliable
- THC accumulates in breast milk at concentrations 8 times higher than maternal plasma due to lipophilicity
- Nicotine replacement therapy is preferred over smoking for breastfeeding mothers who cannot achieve abstinence
Herbal Supplements and Galactagogues
Many mothers use herbal supplements or galactagogues to increase milk supply, but these products are not FDA-regulated and their safety during MAT is largely unstudied. Fenugreek, blessed thistle, and moringa are commonly promoted as lactation aids, but potential interactions with MAT medications and psychiatric medications have not been systematically evaluated. Trust SoCal advises clients to consult with their treatment team before using any herbal supplements.
- Fenugreek can affect blood sugar levels and may interact with medications metabolized by CYP3A4 enzymes
- Domperidone, used as a galactagogue in some countries, has potential cardiac risks and is not FDA-approved for this use in the United States
- Evidence-based strategies such as frequent feeding and breast compression are preferred over unregulated supplements
Hospital Policies and Navigating the NICU Experience
Hospital policies regarding breastfeeding for mothers on MAT vary significantly and may not always reflect current evidence-based guidelines. Some facilities maintain outdated restrictions that discourage or prohibit breastfeeding for women on methadone or buprenorphine, despite endorsement from every major medical organization. Understanding your rights and preparing to advocate for evidence-based breastfeeding support is an important component of birth planning for mothers in MAT.
If an infant requires NICU admission for NAS monitoring or treatment, breastfeeding can and should continue when clinically appropriate. However, NICU environments present logistical challenges including separation from the infant, pump dependency, and staff unfamiliarity with MAT-specific lactation needs. Trust SoCal coordinates with hospital teams to ensure that our clients' breastfeeding plans are communicated and supported regardless of the postpartum care setting.
Advocating for Evidence-Based Hospital Practices
Birth planning for mothers in MAT should include explicit discussion of breastfeeding intentions with the delivery hospital in advance. Providing documentation of MAT provider clearance, relevant ACOG and AAP guidelines, and a written breastfeeding plan to the hospital team reduces confusion and inconsistent advice. Many hospitals that previously restricted breastfeeding for MAT patients have updated their policies in response to provider and patient advocacy.
- Request a pre-delivery meeting with the hospital lactation team to discuss your MAT status and breastfeeding plan
- Bring printed copies of ACOG Committee Opinion 711 to share with any provider who questions breastfeeding eligibility
- Document any refusal to support evidence-based breastfeeding practices and request a patient advocate
Breastfeeding During NICU Admission
NICU admission does not preclude breastfeeding. Rooming-in policies, kangaroo care protocols, and direct breastfeeding during NICU visits are increasingly recognized as therapeutic interventions that improve NAS outcomes. When direct breastfeeding is not possible, expressed breast milk can be provided to the infant via bottle or nasogastric tube, maintaining the nutritional and immunological benefits of human milk even during separation.
- Request kangaroo care sessions to maintain skin-to-skin contact and support breastfeeding during NICU stays
- Hospital-grade breast pumps should be made available to maintain supply when direct feeding is interrupted
- Label and store expressed breast milk according to NICU protocol to ensure your infant receives your milk during separation
Rooming-In as a Standard of Care
The eat, sleep, console model of NAS care increasingly favors rooming-in, where the infant remains with the mother rather than being transferred to the NICU for observation. Research demonstrates that rooming-in with breastfeeding reduces NAS pharmacotherapy needs by up to 50 percent and shortens hospital stays significantly. Trust SoCal advocates for rooming-in whenever clinically safe and supports clients in requesting this approach at their delivery hospital.
- Rooming-in reduces NAS severity scores and pharmacological treatment rates compared to traditional NICU observation
- Maternal presence supports responsive feeding, skin-to-skin contact, and environmental regulation that soothes NAS symptoms
- The eat, sleep, console approach assesses infant function rather than symptom checklists, reducing unnecessary interventions
Emotional and Psychological Aspects of Breastfeeding in Recovery
Breastfeeding carries profound emotional significance for many mothers in recovery. For women whose addiction has been accompanied by feelings of inadequacy, guilt, and shame, successfully nourishing their infant through breastfeeding can be a powerful affirmation of their capacity as mothers. Simultaneously, the pressure to breastfeed can become an additional source of stress and self-judgment when challenges arise. Balanced psychological support around infant feeding decisions is essential.
Trust SoCal therapists address the emotional dimensions of breastfeeding within the context of recovery work. Processing feelings of shame around substance exposure during pregnancy, managing anxiety about medication transfer through breast milk, and building self-compassion when breastfeeding does not go as planned are all therapeutic themes that our clinicians address with maternal clients. The goal is empowered, informed decision-making rather than rigid adherence to any particular feeding method.
Breastfeeding my daughter while in recovery gave me something I never thought I would have again: a feeling of being a good mother. It was not always easy, but the support I received made all the difference.
— Trust SoCal Alumni
Navigating Guilt and Shame
Many mothers in recovery carry guilt about their substance use during pregnancy and may view breastfeeding as an opportunity for redemption or reparation. While breastfeeding is beneficial, framing it as a moral obligation or a way to compensate for substance exposure places an unsustainable burden on mothers already navigating the demands of early recovery. Therapeutic work around self-forgiveness and realistic expectations supports healthier maternal identity development.
- Guilt about prenatal substance exposure is nearly universal among mothers in recovery and should be addressed therapeutically
- Reframing breastfeeding as one of many positive parenting choices reduces the catastrophic thinking that accompanies difficulties
- Self-compassion focused interventions reduce depression and anxiety symptoms while supporting recovery engagement
The Decision Not to Breastfeed
Some mothers in recovery will choose not to breastfeed, and this decision deserves unconditional support. Reasons may include concerns about medication exposure, desire for other caregivers to share feeding responsibilities, body autonomy considerations, or simply personal preference. When this choice is informed and freely made, supporting it without judgment is essential for maternal mental health and recovery confidence.
- Formula feeding is a safe, nutritionally complete alternative that allows shared caregiving responsibilities
- Mothers who choose not to breastfeed should receive lactation suppression support and emotional validation
- The quality of the feeding interaction matters more for infant attachment than the method of feeding
Building Confidence as a Mother in Recovery
Whether breastfeeding or formula feeding, the early postpartum period is a critical time for building maternal confidence and identity. Mothers in recovery often internalize messages that addiction makes them unfit parents. Countering this narrative through successful feeding interactions, responsive caregiving, and therapeutic support lays the foundation for a positive maternal identity that supports long-term recovery and healthy child development.
- Positive early feeding experiences build self-efficacy that generalizes to other parenting domains
- Recovery milestones such as continued sobriety and treatment engagement should be celebrated as evidence of good parenting
- Peer mentoring from mothers further along in recovery provides hope and practical modeling
Trust SoCal Breastfeeding Support Services
Trust SoCal integrates breastfeeding support into our comprehensive maternal recovery programming at our Fountain Valley, Orange County facility. Our approach recognizes that successful breastfeeding during MAT requires coordination across addiction treatment, lactation support, pediatric care, and mental health services. We provide this integrated model to ensure that mothers in our program receive consistent, evidence-based guidance throughout their breastfeeding journey.
Our clinical team includes providers trained in both addiction medicine and perinatal care who understand the specific considerations that apply to breastfeeding during MAT. From prenatal breastfeeding education through weaning support, Trust SoCal walks alongside mothers at every stage. We believe that supporting informed infant feeding decisions, whatever those decisions may be, is a fundamental component of maternal recovery care.
Contact Trust SoCal at (949) 280-8360 to learn more about our maternal recovery program and breastfeeding support services. Our admissions team provides confidential consultations and insurance verification. For breastfeeding crisis support, contact the National Breastfeeding Helpline at 1-800-994-9662 or Postpartum Support International at 1-800-944-4773.
Prenatal Breastfeeding Preparation
Breastfeeding preparation begins during pregnancy at Trust SoCal. Our maternal track includes education on breastfeeding mechanics, colostrum collection and storage, navigating hospital policies, and building a breastfeeding support team. Early preparation significantly increases breastfeeding initiation rates and reduces the likelihood of early discontinuation due to preventable challenges.
- Prenatal education sessions cover breastfeeding basics, MAT-specific considerations, and hospital advocacy strategies
- Colostrum harvesting instruction beginning at 36 weeks ensures a supply of expressed colostrum for the hospital stay
- Birth plan templates include specific breastfeeding preferences and MAT documentation for the delivery team
Postpartum Lactation Support
After delivery, Trust SoCal provides ongoing lactation support through our clinical team and coordination with community lactation consultants. Regular check-ins assess breastfeeding progress, address emerging challenges, and monitor infant growth and feeding adequacy. This sustained support model recognizes that breastfeeding success requires more than a single hospital consultation, particularly for mothers navigating the additional complexities of recovery.
- Weekly breastfeeding check-ins during the first month postpartum address challenges before they become insurmountable
- Coordination with WIC breastfeeding peer counselors provides additional community-based support
- Breast pump provision and instruction ensure mothers can maintain supply during treatment appointments or separations
Integration with Recovery Programming
Breastfeeding support at Trust SoCal is woven into the broader recovery program rather than treated as a separate service. Treatment scheduling accommodates feeding and pumping needs, group therapy sessions provide space for processing breastfeeding experiences, and individual therapy addresses the emotional dimensions of infant feeding within the context of recovery. This integrated approach prevents the fragmentation that often undermines both breastfeeding and recovery outcomes.
- Treatment schedules are built around infant feeding needs to prevent pump-or-miss conflicts
- Designated private pumping spaces are available throughout the treatment facility
- Maternal recovery groups include breastfeeding check-ins as a regular agenda item
Medical Review Board, MD, ABAM
Medical Director & Reviewer
